http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106924727-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16151 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 |
| filingDate | 2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106924727-B |
| titleOfInvention | Preparation method of avian influenza virus H9 subtype inactivated vaccine |
| abstract | The invention belongs to the technical field of biological products for livestock, and particularly relates to a preparation method of an avian influenza virus H9 subtype inactivated vaccine. The invention adopts LMH continuous cell line as carrier cell to proliferate virus, adopts culture medium A composed of glutamine, recombinant human insulin, human serum albumin, transferrin, biotin and growth factor to culture, collects virus liquid, inactivates, and prepares vaccine. The invention adopts the LMH continuous cell line to proliferate the avian influenza H9 subtype virus without additionally adding pancreatin, and the LMH cell has clear background, no exogenous pathogen and easy proliferation, thereby effectively simplifying the process and reducing the cost. The avian influenza virus H9 subtype inactivated vaccine prepared by the invention has high virus content, good stability and high safety, and is an ideal avian influenza virus H9 subtype inactivated vaccine. |
| priorityDate | 2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 901.